Peak Retirement Planning Inc. Boosts Stock Position in Centene Corporation $CNC

Peak Retirement Planning Inc. increased its holdings in Centene Corporation (NYSE:CNC) by 181.6% during the 3rd quarter, Holdings Channel reports. The firm owned 72,201 shares of the company’s stock after buying an additional 46,562 shares during the period. Centene makes up approximately 0.7% of Peak Retirement Planning Inc.’s investment portfolio, making the stock its 28th biggest position. Peak Retirement Planning Inc.’s holdings in Centene were worth $2,576,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Centene during the third quarter valued at approximately $27,000. WPG Advisers LLC lifted its stake in Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares during the period. Bogart Wealth LLC increased its position in Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after purchasing an additional 991 shares during the period. Financial Network Wealth Advisors LLC raised its holdings in Centene by 54.9% in the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares in the last quarter. Finally, Quent Capital LLC purchased a new stake in shares of Centene in the 3rd quarter worth about $45,000. Institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Zacks Research raised shares of Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. The Goldman Sachs Group reissued a “sell” rating and issued a $38.00 target price (up previously from $33.00) on shares of Centene in a research report on Thursday, October 30th. Truist Financial lifted their price target on Centene from $45.00 to $47.00 and gave the company a “buy” rating in a research report on Monday, January 5th. Morgan Stanley increased their price objective on Centene from $28.00 to $38.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 14th. Finally, Robert W. Baird upped their target price on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Centene currently has an average rating of “Hold” and a consensus target price of $40.81.

Centene Trading Down 1.4%

NYSE CNC opened at $42.72 on Tuesday. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $66.81. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.83. The stock’s fifty day moving average price is $41.95 and its 200-day moving average price is $35.64. The stock has a market cap of $21.00 billion, a P/E ratio of -3.95, a P/E/G ratio of 1.00 and a beta of 0.48.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.